ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

AH

Accord Healthcare at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Accord Healthcare takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 1018. Its program centres on choosing immunotherapy as a first-line treatment in lung cancer. It covers both extensive-stage small cell lung cancer and non-small cell lung cancer.

OrganizationESMO 2026 Attendance
AH
Accord Healthcare
Large pharmaExhibitor
Generic and biosimilar medicines company, part of India's Intas Pharmaceuticals, with a large oncology portfolio.
Booth
Exhibiting at Booth 1018
Satellite
Mon Oct 26
18:30–20:00
Accord Healthcare - Navigating immunotherapy options in first-line ES-SCLC and NSCLC
Sponsored session · with Henry Dunant Hospital Center
Lung & thoracic cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Accord Healthcare

Tell us what you sell and we’ll find the people at Accord Healthcare most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction